Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 33% ± 10% | |
lung | 17 studies | 33% ± 13% | |
intestine | 10 studies | 33% ± 9% | |
eye | 8 studies | 29% ± 6% | |
kidney | 7 studies | 38% ± 15% | |
lymph node | 6 studies | 43% ± 18% | |
uterus | 5 studies | 35% ± 8% | |
liver | 5 studies | 33% ± 13% | |
esophagus | 4 studies | 35% ± 18% | |
breast | 4 studies | 32% ± 8% | |
brain | 4 studies | 30% ± 11% | |
placenta | 3 studies | 21% ± 5% | |
bone marrow | 3 studies | 25% ± 7% | |
ovary | 3 studies | 33% ± 12% | |
adrenal gland | 3 studies | 44% ± 21% | |
pancreas | 3 studies | 19% ± 1% | |
skin | 3 studies | 37% ± 3% | |
prostate | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 9098.71 | 21 / 21 | 90% | 135.69 | 454 / 504 |
adrenal gland | 100% | 7215.95 | 258 / 258 | 88% | 86.48 | 202 / 230 |
pancreas | 88% | 10830.21 | 290 / 328 | 96% | 200.76 | 171 / 178 |
lung | 90% | 5711.78 | 521 / 578 | 90% | 117.56 | 1036 / 1155 |
skin | 91% | 6752.67 | 1641 / 1809 | 88% | 70.33 | 416 / 472 |
breast | 97% | 8750.40 | 445 / 459 | 80% | 64.00 | 891 / 1118 |
kidney | 90% | 4013.37 | 80 / 89 | 84% | 144.46 | 759 / 901 |
uterus | 78% | 3480.26 | 133 / 170 | 91% | 153.79 | 419 / 459 |
esophagus | 87% | 5677.32 | 1254 / 1445 | 81% | 71.48 | 148 / 183 |
ovary | 98% | 20377.86 | 177 / 180 | 69% | 47.20 | 298 / 430 |
intestine | 72% | 2574.07 | 699 / 966 | 92% | 83.82 | 485 / 527 |
stomach | 74% | 2520.77 | 264 / 359 | 85% | 63.28 | 244 / 286 |
prostate | 89% | 4836.68 | 217 / 245 | 69% | 40.29 | 345 / 502 |
thymus | 77% | 3119.42 | 505 / 653 | 76% | 55.26 | 459 / 605 |
brain | 49% | 1496.28 | 1292 / 2642 | 94% | 93.18 | 662 / 705 |
liver | 74% | 4370.37 | 167 / 226 | 53% | 36.49 | 216 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.12 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 96% | 129.25 | 43 / 45 |
adipose | 94% | 7839.52 | 1133 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 9591.05 | 1223 / 1335 | 0% | 0 | 0 / 0 |
spleen | 89% | 4404.90 | 215 / 241 | 0% | 0 | 0 / 0 |
muscle | 80% | 4793.84 | 646 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 51.57 | 22 / 29 |
peripheral blood | 72% | 10996.07 | 666 / 929 | 0% | 0 | 0 / 0 |
heart | 59% | 2917.53 | 506 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 6.38 | 16 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032984 | Biological process | protein-containing complex disassembly |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0048011 | Biological process | neurotrophin TRK receptor signaling pathway |
GO_0051607 | Biological process | defense response to virus |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0001764 | Biological process | neuron migration |
GO_0072593 | Biological process | reactive oxygen species metabolic process |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_0030182 | Biological process | neuron differentiation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0001666 | Biological process | response to hypoxia |
GO_0007420 | Biological process | brain development |
GO_0006915 | Biological process | apoptotic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DDIT4 |
Protein name | DNA damage-inducible transcript 4 protein (HIF-1 responsive protein RTP801) (Protein regulated in development and DNA damage response 1) (REDD-1) DNA damage-inducible transcript 4 protein |
Synonyms | REDD1 RTP801 |
Description | FUNCTION: Regulates cell growth, proliferation and survival via inhibition of the activity of the mammalian target of rapamycin complex 1 (mTORC1). Inhibition of mTORC1 is mediated by a pathway that involves DDIT4/REDD1, AKT1, the TSC1-TSC2 complex and the GTPase RHEB. Plays an important role in responses to cellular energy levels and cellular stress, including responses to hypoxia and DNA damage. Regulates p53/TP53-mediated apoptosis in response to DNA damage via its effect on mTORC1 activity. Its role in the response to hypoxia depends on the cell type; it mediates mTORC1 inhibition in fibroblasts and thymocytes, but not in hepatocytes (By similarity). Required for mTORC1-mediated defense against viral protein synthesis and virus replication (By similarity). Inhibits neuronal differentiation and neurite outgrowth mediated by NGF via its effect on mTORC1 activity. Required for normal neuron migration during embryonic brain development. Plays a role in neuronal cell death. . |
Accessions | A0A7P0Z4M7 Q9NX09 ENST00000681898.1 ENST00000491934.3 ENST00000307365.4 |